Cerenovus to make a €50 million investment in Galway site.

Johnson & Johnson neurovascular group Cerenovus invests €50m in their Galway site situated in Ballybrit Business Park.

The investment will be made over the following three years, and 30 new jobs will be created as a result. The funds will be used to expand the company’s research and development efforts, which are part of Johnson & Johnson Medical Devices.

The new financing will allow the Galway plant to continue to be a world-leading centre for stroke treatment development.

Cerenovus has recently extended its Galway location, which now includes a stroke simulation laboratory as well as improved prototype development and testing capabilities.

Meeting and collaboration facilities, as well as a space to allow team and physician partnerships with an emphasis on research, innovation, and product development, have been added to the office space.

According to Micheál Coughlan, Managing Partner InterSearch Ireland and Head of the InterSearch Worldwide Global Medical Devices Practice Group “further investment by J&J in Cerenovus is a positive reflection on the current team and the ability to attract future talent in the Galway region to advance R&D initiatives in the treatment of stoke”

Cerenovus, Galway, Medical device

We use cookies to give you the best online experience. By agreeing you consent the use of cookies in accordance with our Privacy Statement and cookie settings in your Privacy Settings below.

Privacy Settings saved!
Privacy Settings

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

In order to use this website we use the following technically required cookies
  • wordpress_test_cookie

Decline all Services
Accept all Services